+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Uterine Fibroid Treatment Device Market by Product Type (High Intensity Focused Ultrasound, Hysterectomy, Myomectomy), Technology (Cryoablation, High Intensity Focused Ultrasound, Microwave Ablation), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Uterine Fibroid Treatment Device Market by Product Type (High Intensity Focused Ultrasound, Hysterectomy, Myomectomy), Technology (Cryoablation, High Intensity Focused Ultrasound, Microwave Ablation), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Uterine Fibroid Treatment Device Market by Product Type (High Intensity Focused Ultrasound, Hysterectomy, Myomectomy), Technology (Cryoablation, High Intensity Focused Ultrasound, Microwave Ablation), End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5460250
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Uterine Fibroid Treatment Device Market grew from USD 618.32 million in 2024 to USD 684.20 million in 2025. It is expected to continue growing at a CAGR of 10.46%, reaching USD 1.12 billion by 2030.

An In-Depth Exploration of Uterine Fibroid Treatment Technologies and Market Dynamics Setting the Stage for Strategic Decision-Making in Healthcare

The global burden of uterine fibroids remains a pressing concern for clinicians, device manufacturers, and patients alike, driving an intensified focus on innovative treatment modalities. As uterine fibroids affect a substantial proportion of women of reproductive age, the demand for effective, minimally invasive, and fertility-preserving solutions continues to escalate. Advances in imaging, energy delivery mechanisms, and patient monitoring have catalyzed the emergence of diverse technologies that aim to improve clinical outcomes and patient satisfaction.

This executive summary offers a comprehensive introduction to the pivotal factors shaping the uterine fibroid treatment device market, including evolving clinical guidelines, patient preferences, and the intersection of technological innovation with regulatory oversight. Through an integrated lens, this section sets the foundation for understanding how demographic shifts, healthcare infrastructure maturation, and cross-disciplinary research are influencing the trajectory of device development. By framing the landscape’s critical drivers and challenges, this introduction equips decision-makers with the contextual clarity needed to navigate the complexities of a highly dynamic market.

Rapid Innovations and Patient-Centric Advances Reshape the Uterine Fibroid Treatment Landscape Driving Minimally Invasive Care Models Forward

In recent years, the uterine fibroid treatment landscape has undergone transformative shifts driven by the quest for less invasive procedures and enhanced patient experiences. High-intensity focused ultrasound continues to gain traction as a non-invasive option, supported by advancements in real-time imaging that improve targeting accuracy and reduce collateral tissue damage. Concurrently, surgical approaches such as hysterectomy and myomectomy have evolved with the integration of laparoscopic and robotic assistance, allowing clinicians to perform complex resections with smaller incisions and faster recovery times.

Patient-centric care models have further influenced the rise of ambulatory surgical centers as preferred treatment venues, where streamlined protocols and same-day discharge options cater to individuals seeking convenience without compromising safety. Additionally, the proliferation of digital health platforms has enabled remote monitoring and teleconsultation, facilitating pre- and post-operative care coordination and improving adherence to follow-up regimens. Collectively, these shifts underscore a move toward tailored therapies that balance efficacy, safety, and patient quality of life, setting new benchmarks for treatment standards and reimbursement frameworks.

Comprehensive Assessment of 2025 United States Tariff Policies and Their Broad-Spectrum Effects on Uterine Fibroid Device Supply Chains and Costs

The implementation of new United States tariff measures in 2025 has introduced a complex layer of cost considerations across the uterine fibroid device supply chain. Imported equipment components and specialty consumables have faced increased duties, prompting manufacturers to reassess sourcing strategies and negotiate with international suppliers. In response, several original equipment manufacturers have explored near-shoring assembly operations to mitigate duty burdens, while distributors have adjusted pricing frameworks to preserve margin integrity without undermining market competitiveness.

These tariff-induced cost pressures have also influenced capital investment decisions among end users, with hospitals and specialized fibroid centers delaying non-urgent upgrades and prioritizing devices with proven cost-benefit profiles. Clinics and ambulatory surgical centers have sought bundled purchasing agreements and group procurement models to leverage volume discounts, thereby counterbalancing the elevated duties. Over time, sustained tariff impacts may accelerate domestic manufacturing initiatives and incentivize innovative supply chain collaborations, reshaping the market’s geographic production footprint and fostering resilience against future policy fluctuations.

Granular Analysis of Product, Technology, End-User, and Distribution Channel Segmentation Reveals Critical Pathways to Market Optimization

A nuanced examination of product type segmentation reveals that high intensity focused ultrasound stands out for its non-invasive profile and growing adoption in outpatient settings, while hysterectomy subtypes-abdominal, laparoscopic, and vaginal-continue to address cases where definitive fibroid removal is indicated. Myomectomy subcategories, including hysteroscopic, laparoscopic, and open techniques, offer a spectrum of invasiveness tailored to fibroid size and patient fertility goals. Radiofrequency ablation and uterine artery embolization remain important, less invasive alternatives, particularly for patients seeking uterine preservation.

When assessing technology frameworks, cryoablation emerges as a precise energy modality with minimal collateral damage, complementing the more established microwave ablation and radiofrequency ablation platforms. High intensity focused ultrasound maintains momentum as a non-thermal option supported by real-time imaging advancements. End users span ambulatory surgical centers prioritizing efficiency and reduced hospital stays, clinics seeking office-based procedures, hospitals equipped for complex case management, and specialized fibroid centers offering multidisciplinary care pathways.

Distribution channels play a vital role in market penetration, with direct sales enabling close collaboration between manufacturers and key accounts, distributors extending reach into diverse facility networks, and e-commerce platforms streamlining small-order procurement for clinics and ambulatory settings. Understanding the interplay among these segments is critical for optimizing product positioning and aligning resource allocation with evolving clinical needs.

Comparative Evaluation of Regional Market Behaviors Across Americas, Europe Middle East Africa, and Asia-Pacific Highlighting Adoption and Growth Drivers

Regional dynamics in the Americas are shaped by robust healthcare infrastructure, patient advocacy initiatives, and reimbursement models that increasingly support minimally invasive and uterus-preserving therapies. In North America, high physician awareness and established referral networks facilitate adoption of advanced device technologies, while Latin American markets display growing demand amid expanding hospital capacity and investment in women’s health programs.

In Europe, the Middle East, and Africa, heterogeneous regulatory landscapes affect device approvals and market entry timelines. Western European nations benefit from supportive public health policies and centralized purchasing bodies that drive standardized procurement, whereas Middle Eastern and African regions experience infrastructure variability that creates pockets of rapid uptake alongside areas awaiting capacity development. Collaborative efforts among regional health authorities are progressively harmonizing guidelines, opening avenues for broader adoption of advanced fibroid treatment options.

The Asia-Pacific region is witnessing accelerated growth powered by rising healthcare expenditure, expanding medical tourism hubs, and increasing awareness of women’s reproductive health. Countries with developed healthcare ecosystems are swiftly integrating novel technologies, while emerging markets emphasize cost-effective solutions and local manufacturing partnerships. These regional distinctions underscore the need for tailored market entry strategies and partnership models.

Strategic Competitive Intelligence Spotlighting Leading Uterine Fibroid Treatment Device Providers and Their Differentiation Tactics for Market Leadership

Leading device manufacturers remain focused on enhancing product portfolios through strategic collaborations, targeted R&D investments, and tactical acquisitions. Industry frontrunners have launched next-generation ablation systems with improved user interfaces and precision energy delivery, while others have expanded their footprints by securing distribution alliances in high-growth markets. Technology partnerships with imaging and robotics developers are enabling integrated solutions that streamline procedural workflows and reduce operator dependency.

Competitive differentiation is increasingly driven by real-world evidence generation and post-market clinical registries, as providers and payers seek robust data on safety, efficacy, and long-term patient outcomes. Several key players are leveraging digital platforms to offer training, procedural planning tools, and remote support services, fostering deeper customer engagement and reinforcing brand loyalty. Additionally, sustainability initiatives focusing on reusable instrument components and environmentally friendly packaging are emerging as value drivers in regions with stringent environmental regulations.

Actionable Strategic Guidance for Industry Stakeholders to Enhance Innovation, Optimize Market Access, and Drive Sustainable Growth in Treatment Devices

Manufacturers should prioritize modular device designs that accommodate both existing surgical suites and emerging ambulatory care environments, ensuring maximum flexibility for end users. Strengthening partnerships with imaging providers and robotic system vendors can unlock integrated procedural solutions that enhance precision and reduce learning curves. Simultaneously, engaging key opinion leaders and patient advocacy groups will amplify clinical awareness and drive guideline endorsements for novel therapeutic options.

From a market access perspective, building value-based evidence that demonstrates overall healthcare cost savings and patient quality of life improvements will be crucial when negotiating with payers and health systems. Tailored market entry strategies should consider regional reimbursement landscapes and leverage local manufacturing or assembly partnerships to mitigate tariff impacts. Finally, investing in digital health platforms that support remote monitoring, teleconsultation, and predictive analytics will position manufacturers as comprehensive solution providers, fostering long-term customer relationships.

Robust Research Framework Detailing Methodologies Employed to Ensure Data Integrity, Validity, and Comprehensive Coverage in Market Analysis

This research integrates primary insights from in-depth interviews with leading clinicians, procurement specialists, and device executives across multiple regions. These qualitative perspectives are complemented by systematic secondary research, which encompasses regulatory filings, peer-reviewed publications, conference proceedings, and public company disclosures. Data triangulation techniques ensure consistency across sources, while a rigorous validation process confirms the reliability of key findings.

Quantitative analyses employ a bottom-up approach to assess adoption patterns and device deployment trends by synthesizing procedure volumes, technology penetration rates, and facility readiness assessments. The methodology also incorporates sensitivity analyses to account for variations in regulatory approval timelines, tariff scenarios, and reimbursement policy shifts. All research activities adhere to established ethical guidelines, safeguarding confidentiality and objectivity throughout the analytical framework.

Cohesive Synthesis of Core Findings Underscoring Transformative Trends, Segment Insights, and Strategic Imperatives for Uterine Fibroid Devices

This synthesis of market insights underscores a clear trajectory toward less invasive, patient-focused fibroid treatment modalities fueled by imaging advancements, digital health integration, and strategic industry collaborations. The interplay of tariff policies, segmentation nuances, and regional idiosyncrasies highlights the importance of adaptive supply chain strategies and localized market approaches. Competitive dynamics are intensifying as manufacturers differentiate through integrated solutions, real-world data generation, and sustainability initiatives.

Moving forward, industry stakeholders must balance the imperatives of innovation, cost containment, and regulatory compliance to capitalize on emerging growth opportunities. By leveraging the actionable recommendations outlined herein-ranging from modular device development to value-based evidence creation-companies can navigate complex policy landscapes, align with evolving clinical protocols, and foster enduring partnerships with both providers and patients. This conclusion reaffirms the criticality of a holistic, data-driven approach to achieving sustainable market leadership in the uterine fibroid treatment device arena.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • High Intensity Focused Ultrasound
    • Hysterectomy
      • Abdominal
      • Laparoscopic
      • Vaginal
    • Myomectomy
      • Hysteroscopic
      • Laparoscopic
      • Open
    • Radiofrequency Ablation
    • Uterine Artery Embolization
  • Technology
    • Cryoablation
    • High Intensity Focused Ultrasound
    • Microwave Ablation
    • Radiofrequency Ablation
  • End User
    • Ambulatory Surgical Centers
    • Clinics
    • Hospitals
    • Specialized Fibroid Centers
  • Distribution Channel
    • Direct Sales
    • Distributors
    • E Commerce
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Johnson & Johnson
  • Medtronic plc
  • Hologic, Inc.
  • Boston Scientific Corporation
  • Olympus Corporation
  • GE HealthCare Technologies Inc.
  • Siemens Healthineers AG
  • Merit Medical Systems, Inc.
  • Insightec Ltd.
  • Chongqing Haifu MedTech Co., Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of real-time MRI guidance in uterine fibroid ablation procedures
5.2. Development of biodegradable embolic microspheres for targeted fibroid therapy
5.3. Rising adoption of outpatient radiofrequency ablation systems by ambulatory centers
5.4. Advancements in robotic-assisted fibroid removal enhancing surgical precision
5.5. Increasing investment in US-based minimally invasive fibroid device startups
5.6. Regulatory approvals accelerating market entry for novel fibroid management devices
5.7. Growing demand for pain-free transcervical ultrasound ablation in young females
5.8. Collaborations between device manufacturers and AI firms for predictive treatment
5.9. Innovations in single-use hysteroscopic platforms reducing cross-contamination risk
5.10. Focus on patient-specific 3D printed models for preoperative fibroid planning
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Uterine Fibroid Treatment Device Market, by Product Type
8.1. Introduction
8.2. High Intensity Focused Ultrasound
8.3. Hysterectomy
8.3.1. Abdominal
8.3.2. Laparoscopic
8.3.3. Vaginal
8.4. Myomectomy
8.4.1. Hysteroscopic
8.4.2. Laparoscopic
8.4.3. Open
8.5. Radiofrequency Ablation
8.6. Uterine Artery Embolization
9. Uterine Fibroid Treatment Device Market, by Technology
9.1. Introduction
9.2. Cryoablation
9.3. High Intensity Focused Ultrasound
9.4. Microwave Ablation
9.5. Radiofrequency Ablation
10. Uterine Fibroid Treatment Device Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.4. Hospitals
10.5. Specialized Fibroid Centers
11. Uterine Fibroid Treatment Device Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
11.4. E Commerce
12. Americas Uterine Fibroid Treatment Device Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Uterine Fibroid Treatment Device Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Uterine Fibroid Treatment Device Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Johnson & Johnson
15.3.2. Medtronic plc
15.3.3. Hologic, Inc.
15.3.4. Boston Scientific Corporation
15.3.5. Olympus Corporation
15.3.6. GE HealthCare Technologies Inc.
15.3.7. Siemens Healthineers AG
15.3.8. Merit Medical Systems, Inc.
15.3.9. Insightec Ltd.
15.3.10. Chongqing Haifu MedTech Co., Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. UTERINE FIBROID TREATMENT DEVICE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UTERINE FIBROID TREATMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. UTERINE FIBROID TREATMENT DEVICE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. UTERINE FIBROID TREATMENT DEVICE MARKET: RESEARCHAI
FIGURE 24. UTERINE FIBROID TREATMENT DEVICE MARKET: RESEARCHSTATISTICS
FIGURE 25. UTERINE FIBROID TREATMENT DEVICE MARKET: RESEARCHCONTACTS
FIGURE 26. UTERINE FIBROID TREATMENT DEVICE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. UTERINE FIBROID TREATMENT DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABDOMINAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY ABDOMINAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY VAGINAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY VAGINAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTEROSCOPIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTEROSCOPIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY OPEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY OPEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY UTERINE ARTERY EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY UTERINE ARTERY EMBOLIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY CRYOABLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY CRYOABLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MICROWAVE ABLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MICROWAVE ABLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SPECIALIZED FIBROID CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY SPECIALIZED FIBROID CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY E COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 93. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 94. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 95. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
TABLE 96. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2025-2030 (USD MILLION)
TABLE 97. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2018-2024 (USD MILLION)
TABLE 98. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2025-2030 (USD MILLION)
TABLE 99. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 100. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 101. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. CANADA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 106. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 107. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
TABLE 108. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2025-2030 (USD MILLION)
TABLE 109. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2018-2024 (USD MILLION)
TABLE 110. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2025-2030 (USD MILLION)
TABLE 111. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 112. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 113. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. MEXICO UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
TABLE 170. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2025-2030 (USD MILLION)
TABLE 171. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2018-2024 (USD MILLION)
TABLE 172. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2025-2030 (USD MILLION)
TABLE 173. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 174. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 175. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. GERMANY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
TABLE 182. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2025-2030 (USD MILLION)
TABLE 183. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2018-2024 (USD MILLION)
TABLE 184. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2025-2030 (USD MILLION)
TABLE 185. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 186. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 187. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. FRANCE UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2025-2030 (USD MILLION)
TABLE 195. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2018-2024 (USD MILLION)
TABLE 196. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2025-2030 (USD MILLION)
TABLE 197. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 198. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 199. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. RUSSIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
TABLE 206. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2025-2030 (USD MILLION)
TABLE 207. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2018-2024 (USD MILLION)
TABLE 208. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2025-2030 (USD MILLION)
TABLE 209. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 210. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 211. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. ITALY UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 216. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 217. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
TABLE 218. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2025-2030 (USD MILLION)
TABLE 219. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2018-2024 (USD MILLION)
TABLE 220. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2025-2030 (USD MILLION)
TABLE 221. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 222. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 223. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. SPAIN UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2025-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2018-2024 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2025-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2025-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2018-2024 (USD MILLION)
TABLE 244. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2025-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 246. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. SAUDI ARABIA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2025-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2018-2024 (USD MILLION)
TABLE 256. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2025-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 258. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. SOUTH AFRICA UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
TABLE 266. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2025-2030 (USD MILLION)
TABLE 267. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2018-2024 (USD MILLION)
TABLE 268. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2025-2030 (USD MILLION)
TABLE 269. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 270. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 271. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. DENMARK UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 277. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
TABLE 278. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2025-2030 (USD MILLION)
TABLE 279. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2018-2024 (USD MILLION)
TABLE 280. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2025-2030 (USD MILLION)
TABLE 281. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. NETHERLANDS UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 288. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 289. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2018-2024 (USD MILLION)
TABLE 290. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY HYSTERECTOMY, 2025-2030 (USD MILLION)
TABLE 291. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2018-2024 (USD MILLION)
TABLE 292. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY MYOMECTOMY, 2025-2030 (USD MILLION)
TABLE 293. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 294. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 295. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. QATAR UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 300. FINLAND UTERINE FIBROID TREATMENT DEVICE MARKET

Samples

Loading
LOADING...

Companies Mentioned

  • Johnson & Johnson
  • Medtronic plc
  • Hologic, Inc.
  • Boston Scientific Corporation
  • Olympus Corporation
  • GE HealthCare Technologies Inc.
  • Siemens Healthineers AG
  • Merit Medical Systems, Inc.
  • Insightec Ltd.
  • Chongqing Haifu MedTech Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 684.2 Million
Forecasted Market Value ( USD ) by 2030 $ 1120 Million
Compound Annual Growth Rate10.4%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Uterine Fibroids Treatment Devices Market Size, Share & Trends Analysis Report By Technology, By Mode Of Treatment, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Uterine Fibroids Treatment Devices Market Size, Share & Trends Analysis Report By Technology, By Mode Of Treatment, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Uterine Fibroid Embolization Device Market Report 2025 - Product Image

Uterine Fibroid Embolization Device Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Uterine Fibroid Treatment Devices - Global Strategic Business Report - Product Image

Uterine Fibroid Treatment Devices - Global Strategic Business Report

  • Report
  • 276 Pages
  • Global
From
Uterine Fibroid Treatment Device Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Uterine Fibroid Treatment Device Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Uterine Fibroid Treatment Device Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 - Product Image

Uterine Fibroid Treatment Device Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

  • Report
  • 150 Pages
  • Global
From

About the Uterine Fibroid Treatment Device Market

The Uterine Fibroid Treatment Device market is a subset of the medical devices sector that centers on products intended for the diagnosis, treatment, or management of uterine fibroids. Uterine fibroids, also known as leiomyomas or myomas, are noncancerous growths of the uterus that often appear during childbearing years. Treatment devices vary in function and application, ranging from diagnostic imaging equipment, such as ultrasound, to therapeutic technologies including minimally invasive surgery tools, endometrial ablation devices, and uterine fibroid embolization materials. With a focus on patient safety and outcome, these devices aim to provide alternatives to traditional surgical procedures, like hysterectomy, that have greater risks and longer recovery times. The market is driven by factors such as the prevalence of the condition among women, technological advancements, and the rising preference for minimally invasive procedures. Prominent players in the Uterine Fibroid Treatment Device market consist of companies that specialize in women's health and surgical products. Some of these include Hologic, Inc., which offers a suite of fibroid treatment solutions; AbbVie Inc., known for its medical devices and pharmaceuticals; Boston Scientific Corporation, which develops minimally invasive medical products; and Medtronic, offering a broad range of medical technologies, including those for treating uterine conditions. Other notable companies include Siemens Healthineers, GE Healthcare, and Philips Healthcare, which provide advanced imaging systems for the diagnosis of uterine Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.